US Stock MarketDetailed Quotes

LYEL Lyell Immunopharma

Watchlist

0.945
+0.025+2.67%

Close Nov 29 13:00 ET

0.938
-0.007-0.74%

Post 17:01 ET

263.89MMarket Cap-1196P/E (TTM)

Lyell Immunopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Lyell Immunopharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 0.000	--
--	2024/Q4	-- / 0.000	--
--	2024/Q3	34.000K / 0.000	--
--	2024/Q2	13.000K / 0.000	--
--	2024/Q1	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 0.000--

--2024/Q4-- / 0.000--

--2024/Q334.000K / 0.000--

--2024/Q213.000K / 0.000--

--2024/Q10.000 / 0.000--

Unlock Free Earnings Estimates

Open Account

Lyell Immunopharma Earnings Reports

Lyell Immunopharma | 10-Q: Q3 2024 Earnings Report

Nov 7 16:26 ET

Lyell Immunopharma | 8-K: Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2024

Nov 7 16:14 ET

Lyell Immunopharma | 10-Q: Q2 2024 Earnings Report

Aug 7 22:19 ET

Lyell Immunopharma | 8-K: Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2024

Aug 7 16:13 ET

Analyst Rating

Updated: Nov 30, 2024

Hold

Buy
0.00%
Hold
100.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall